Jia Y, Zhang Y, Qiao C, Liu G, Zhao Q, Zhou T, et al
The art of tissue-specific and disease-specific dosing may emerge in the not-too-distant future: Rather than using the current pharmacologic doses of GLP-1s to soak receptors throughout the body, we may learn how to apply much more tailored brush strokes to effectively treat, say, dementia or rheumatoid arthritis
Development and evaluation of 18F-TTCO-Cys40-Exendin-4: A PET probe for imaging transplanted islets
It tackles the complex biological factors that often hinder sustainable weight loss
They are both medications being studied for obesity and diabetes treatment, but they work in slightly different ways in the body to achieve similar goals of controlling blood sugar levels and promoting weight loss
Efficacy and safety of once-weekly semaglutide 20 mg versus 10 mg inpatients with type 2diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial